Rogers, K. A., Muluneh, B., Qureshi, Z. P., He, J., Bokun, A., Ding, Z., . . . Fradley, M. A comparison of healthcare resource utilization and costs between patients with chronic lymphocytic leukemia treated with first-line ibrutinib or acalabrutinib using two large US real-world databases. Becaris Publishing Limited.
Chicago Style (17th ed.) CitationRogers, Kerry A., et al. A Comparison of Healthcare Resource Utilization and Costs Between Patients with Chronic Lymphocytic Leukemia Treated with First-line Ibrutinib or Acalabrutinib Using Two Large US Real-world Databases. Becaris Publishing Limited.
MLA (9th ed.) CitationRogers, Kerry A., et al. A Comparison of Healthcare Resource Utilization and Costs Between Patients with Chronic Lymphocytic Leukemia Treated with First-line Ibrutinib or Acalabrutinib Using Two Large US Real-world Databases. Becaris Publishing Limited.